Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Int Heart J ; 62(4): 935-937, 2021 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-34234072

RESUMEN

Spontaneous spinal epidural hematoma (SSEH) is considered to be a relatively rare disease that can result in serious neurological sequelae. The pathogenesis and risk factors of SSEH are still unknown, and its differential diagnosis varies widely. Misdiagnosis with more common conditions such as stroke or aortic syndromes can occur. We report the case of a 27-year-old man who developed sudden upper back pain with no specific precipitant. Five days later, he visited our emergency department complaining of weakness in both lower limbs and dysuria. He had a history of intracardiac repair and a Blalock-Park procedure for an interrupted aortic arch and ventricular septal defect in infancy. Additionally, he had undergone an aortic root dilatation and aortic valve replacement at the age of 10 because of progression of aortic and supra-aortic stenosis and had received chronic anticoagulation and antiplatelet therapy with warfarin and aspirin, respectively. An emergency spine magnetic resonance imaging scan indicated a mass at the Th3-Th5 level with severe compression of the dural sac and the spinal cord. Emergency excision showed a spinal epidural hematoma. Mild postoperative gait disturbance and dysuria persisted, requiring rehabilitation and intermittent self-urethral catheterization. As patients with adult congenital heart disease have an increased risk of bleeding, they may be at risk of developing SSEH. However, this is the first report to describe such an association.


Asunto(s)
Cardiopatías Congénitas/complicaciones , Hematoma Espinal Epidural/inducido químicamente , Complicaciones Posoperatorias/inducido químicamente , Adulto , Anticoagulantes/efectos adversos , Estenosis de la Válvula Aórtica/cirugía , Aspirina/efectos adversos , Defectos del Tabique Interventricular , Implantación de Prótesis de Válvulas Cardíacas , Hematoma Espinal Epidural/diagnóstico por imagen , Humanos , Imagen por Resonancia Magnética , Masculino , Inhibidores de Agregación Plaquetaria/efectos adversos , Warfarina/efectos adversos
2.
J Infect Chemother ; 27(3): 497-502, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33303359

RESUMEN

INTRODUCTION: There is some evidence that Bordetella pertussis (B. pertussis) can co-infect with viral respiratory infections in young infants. METHODS: B. pertussis infection was studied by culture, polymerase chain reaction (PCR), and loop-mediated isothermal amplification (LAMP) from nasopharyngeal swabs (NPSs) in 49 infants < 12 months of age, who were admitted for lower respiratory tract infections during the winter season. Seven other possible viral pathogens were documented by antigen detection or PCR in NPSs. The clinical feature of infants with mixed infection of B. pertussis and respiratory viruses were examined. RESULTS: Overall, B. pertussis infection was found in 10 (20.4%) cases, nine were less than 6 months of age and seven were unvaccinated. Viral etiology was found in 41 (84%) cases and pertussis-viral co-infection was present in eight patients, five of whom had mixed infection with respiratory syncytial virus. Only the presence of staccato coughing, cyanosis, and lymphocytosis were significantly different in B. pertussis-positive cases compared with B. pertussis-negative cases. Of the 10 pertussis cases, only the culture-positive cases showed the typical symptoms and laboratory findings of pertussis in addition to virus-associated respiratory symptoms with severe hospital course, whereas cases identified as DNA-positive lacked the characteristics of pertussis and their clinical severities were the same as B. pertussis-negative cases. CONCLUSION: In the absence of typical paroxysmal cough and lymphocytosis, we should carefully consider diagnosis of pertussis in young children hospitalized for presumed viral respiratory illness according to local epidemiological surveillance.


Asunto(s)
Infecciones del Sistema Respiratorio , Tos Ferina , Bordetella pertussis/genética , Niño , Preescolar , Humanos , Lactante , Técnicas de Diagnóstico Molecular , Técnicas de Amplificación de Ácido Nucleico , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/epidemiología , Estaciones del Año , Tos Ferina/diagnóstico , Tos Ferina/epidemiología
3.
Jpn J Infect Dis ; 71(1): 68-71, 2018 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-29279439

RESUMEN

Streptococcus gallolyticus subsp. pasteurianus, previously recognized as S. bovis biotype II/2, is an uncommon yet important cause of invasive infection in young infants. Here, we report the first case of ventriculitis that was unexpectedly diagnosed in the course of neonatal meningitis due to S. gallolyticus subsp. pasteurianus, and we review the relevant literature. A 28-day-old male infant from Japan presented with fever, lethargy, and irritability. S. bovis was isolated from blood and the cerebrospinal fluid culture and was then identified as S. gallolyticus subsp. pasteurianus. Intravenous antibiotic therapy was initiated, which helped improve the clinical course of the disease; however, the patient presented ventriculitis-related complications diagnosed using follow-up magnetic resonance imaging (MRI) on day 12 of hospitalization. Ampicillin was administered for 21 days and discontinued after the patient showed improvement, according to MRI findings. The patient was discharged without sequelae. Ventriculitis is a rare complication of childhood meningitis due to S. gallolyticus subsp. pasteurianus. However, it may have been underdiagnosed, especially in cases with no specific manifestations similar to the present case. We suggest that MRI should be performed to screen for ventriculitis in the course of meningitis to avoid failure in treatment.


Asunto(s)
Ventriculitis Cerebral/etiología , Enfermedades del Recién Nacido/microbiología , Meningitis Bacterianas/microbiología , Infecciones Estreptocócicas/microbiología , Streptococcus gallolyticus , Ventriculitis Cerebral/diagnóstico , Ventriculitis Cerebral/diagnóstico por imagen , Ventriculitis Cerebral/microbiología , Humanos , Recién Nacido , Enfermedades del Recién Nacido/diagnóstico , Imagen por Resonancia Magnética , Masculino , Meningitis Bacterianas/complicaciones , Neuroimagen , Infecciones Estreptocócicas/complicaciones
4.
Pediatr Int ; 59(12): 1266-1269, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28833971

RESUMEN

BACKGROUND: Adhesive strapping for umbilical hernia has been re-evaluated as a promising treatment. We evaluated the influence of adhesive strapping on the outcome of umbilical hernia. METHODS: We retrospectively evaluated patients with umbilical hernia referred to the present institution from April 2011 to December 2015. Patients who were treated with adhesive strapping were compared with an observation alone group. The adhesive strapping group was also subdivided into two groups: the cure group and the treatment failure group. RESULTS: A total of 212 patients with umbilical hernia were referred to the present institution. Eighty-nine patients were treated with adhesive strapping, while 27 had observation only. The cure rate in the adhesive strapping group was significantly higher than that in the observation group. The duration of treatment of the adhesive strapping group was significantly shorter than that of the observation group. In the adhesive strapping group, the patients in the cure group were treated significantly earlier than those in the treatment failure group (P < 0.001). Furthermore, even in cases of umbilical hernia non-closure, surgical repair was easier after adhesive strapping. CONCLUSION: Adhesive strapping represents a promising treatment for umbilical hernia. To achieve the best results, adhesive strapping should be initiated as early as possible.


Asunto(s)
Adhesivos , Vendajes , Hernia Umbilical/terapia , Femenino , Estudios de Seguimiento , Humanos , Recién Nacido , Masculino , Estudios Retrospectivos , Resultado del Tratamiento , Espera Vigilante
5.
Intern Med ; 53(3): 205-13, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24492688

RESUMEN

OBJECTIVE: Disseminated intravascular coagulation (DIC) is a clinical condition with high mortality that is characterized by the systemic activation of coagulation pathways resulting in multiple organ failure. Although no standard treatment for DIC has been established, recent reports have indicated that recombinant human soluble thrombomodulin (rTM) is effective against DIC. METHODS: To elucidate the clinical characteristics and outcomes of DIC, we retrospectively analyzed 92 DIC patients who were treated with rTM at Miyazaki Prefectural Hospital over a 4-year period (62 patients had infectious diseases and 30 patients had hematological diseases). A diagnosis of DIC was made based on the diagnostic criteria of the Japanese Association for Acute Medicine (JAAM) and Japanese Ministry of Health and Welfare (JMHW) for infectious diseases and hematological diseases, respectively. In addition to treating the underlying disease, rTM was administered for six consecutive days. RESULTS: In this study, 49 of the 92 DIC patients (53.3%) experienced resolution of DIC seven days after administration (46.8% patients with infectious disease and 66.7% with hematological disease). A higher survival rate was observed after a 28-day observation period in 69 of the 92 patients (75.0%) (72.6% of the patients with infectious disease and 80.0% of the patients with hematological disease). A lower DIC score at the initiation of rTM treatment was closely related to a higher rate of resolution of DIC. CONCLUSION: Our findings indicate that rTM therapy is an effective, safe and feasible treatment for DIC patients. Furthermore, making an accurate and early diagnosis of DIC and providing subsequent immediate treatment with rTM may improve the resolution of DIC.


Asunto(s)
Enfermedades Transmisibles/tratamiento farmacológico , Coagulación Intravascular Diseminada/tratamiento farmacológico , Enfermedades Hematológicas/tratamiento farmacológico , Trombomodulina/uso terapéutico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Enfermedades Transmisibles/diagnóstico , Enfermedades Transmisibles/mortalidad , Coagulación Intravascular Diseminada/diagnóstico , Coagulación Intravascular Diseminada/mortalidad , Femenino , Enfermedades Hematológicas/diagnóstico , Enfermedades Hematológicas/mortalidad , Humanos , Masculino , Persona de Mediana Edad , Mortalidad/tendencias , Proteínas Recombinantes/uso terapéutico , Estudios Retrospectivos , Resultado del Tratamiento , Adulto Joven
6.
J Clin Virol ; 51(1): 68-72, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21324735

RESUMEN

BACKGROUND: Definitive diagnosis is crucial in reducing morbidity and mortality from pandemic influenza A H1N1 2009 (A/H1N1/2009), especially in high-risk populations. We recently developed a rapid diagnosis kit (RDK) capable of specifically detecting A/H1N1/2009. OBJECTIVES: To evaluate the diagnostic capability of the RDK in a multicenter, prospective trial. STUDY DESIGN: Samples were obtained by nasal swab from patients with suspected influenza. The diagnostic capability of the RDK was compared with that of the standard, real-time reverse transcription-polymerase chain reaction (RT-PCR) method. RESULTS: Of 266 patients who met the criteria, 122 and 92 were positive for A/H1N1/2009 influenza by PCR and by the newly developed RDK, respectively. The sensitivity, specificity and positive and negative predictive values of the RDK were 73.0%, 97.9%, 96.7% and 81.0%, respectively. A/H1N1/2009 detection rates by the RDK were significantly lower in samples obtained from patients more than 3 days after onset than in samples obtained between 1 and 2 days. CONCLUSIONS: The A/H1N1/2009-specific RDK is a reliable test that can be used easily at a patient's bedside for rapid diagnosis of A/H1N1/2009. This test will be of key importance in the control of A/H1N1/2009.


Asunto(s)
Anticuerpos Monoclonales/inmunología , Antígenos Virales/inmunología , Subtipo H1N1 del Virus de la Influenza A/aislamiento & purificación , Gripe Humana/diagnóstico , Juego de Reactivos para Diagnóstico/normas , Adolescente , Distribución por Edad , Niño , Preescolar , Cromatografía de Afinidad , Intervalos de Confianza , Femenino , Humanos , Lactante , Subtipo H1N1 del Virus de la Influenza A/inmunología , Gripe Humana/inmunología , Gripe Humana/virología , Japón , Masculino , Pandemias , Estudios Prospectivos , Juego de Reactivos para Diagnóstico/virología , Sensibilidad y Especificidad , Distribución por Sexo , Factores de Tiempo
7.
Kidney Int ; 78(2): 207-14, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20200500

RESUMEN

Recent linkage analyses of nondiabetic African-American patients with focal segmental glomerulosclerosis (FSGS) have identified MYH9, encoding nonmuscle myosin heavy chain IIA (NMMHC-IIA), as a gene having a critical role in this disease. Abnormalities of the MYH9 locus also underlie rare autosomal dominant diseases such as May-Hegglin anomaly, and Sebastian, Epstein (EPS), and Fechtner (FTNS) syndromes that are characterized by macrothrombocytopenia and cytoplasmic inclusion bodies in granulocytes. Among these diseases, patients with EPS or FTNS develop progressive nephritis and hearing disability. We analyzed clinical features and pathophysiological findings of nine EPS-FTNS patients with MYH9 mutations at the R702 codon hot spot. Most developed proteinuria and/or hematuria in early infancy and had a rapid progression of renal impairment during adolescence. Renal histopathological findings in one patient showed changes compatible with FSGS. The intensity of immunostaining for NMMHC-IIA in podocytes was decreased in this patient compared with control patients. Thus, MYH9 R702 mutations display a strict genotype-phenotype correlation, and lead to the rapid deterioration of podocyte structure. Our results highlight the critical role of NMMHC-IIA in the development of FSGS.


Asunto(s)
Enfermedades Renales/etiología , Proteínas Motoras Moleculares/genética , Mutación , Cadenas Pesadas de Miosina/genética , Proteinuria/etiología , Adolescente , Adulto , Niño , Preescolar , Progresión de la Enfermedad , Femenino , Pérdida Auditiva Sensorineural/genética , Humanos , Masculino , Nefritis Hereditaria/genética , Trombocitopenia/genética , Adulto Joven
8.
Neurol Med Chir (Tokyo) ; 50(2): 174-7, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20185890

RESUMEN

An infant presented with a rare cervical (non-terminal) myelocystocele as a congenital skin-covered mass located in the midline of the posterior aspect of her neck. Magnetic resonance (MR) imaging and computed tomography showed a cystic mass filled with cerebrospinal fluid in the midline of the posterior aspect of the neck, with a fibrous streak extending from the bottom of the sac to the dorsal surface of the cervical cord. Brain MR imaging also showed a dilated ventricular system and Chiari type II malformation. The patient underwent plastic repair of the lesion, which was diagnosed as myelocystocele. After the surgery, the patient experienced respiratory distress. Ultrasound tomography from the anterior fontanel revealed deterioration of hydrocephalus, so a ventriculoperitoneal shunt was inserted, and the respiratory distress improved. The present case illustrates the possibility of rapidly worsening of hydrocephalus and Chari type II malformation after surgical repair of cervical (non-terminal) myelocystocele.


Asunto(s)
Malformación de Arnold-Chiari/complicaciones , Malformación de Arnold-Chiari/patología , Hidrocefalia/etiología , Hidrocefalia/patología , Meningomielocele/etiología , Meningomielocele/patología , Enfermedad Aguda , Derivaciones del Líquido Cefalorraquídeo , Vértebras Cervicales/anomalías , Vértebras Cervicales/patología , Trastornos de Deglución/etiología , Progresión de la Enfermedad , Femenino , Humanos , Hidrocefalia/fisiopatología , Recién Nacido , Meningomielocele/fisiopatología , Procedimientos Neuroquirúrgicos , Procedimientos de Cirugía Plástica , Insuficiencia Respiratoria/etiología , Médula Espinal/anomalías , Médula Espinal/patología , Médula Espinal/fisiopatología , Factores de Tiempo , Resultado del Tratamiento , Ventriculostomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA